Mutated DNA Restored to Normal in Gene Therapy Advance
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Roche announces hub for cardiovascular, renal and metabolism research
CVRM product development global head and senior vice-president Manu Chakravarthy will be the centre's site head.
Fierce Pharma7h
GSK, Novartis, Lilly among Big Pharmas celebrating International Women’s Day 2025
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
Optometry Advisor8h
FDA Approves TNKase for Acute Ischemic Stroke
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.